nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Rash maculo-papular—Mycophenolate mofetil—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Cefoxitin—Renal failure acute—Lisinopril—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Cefoxitin—Jaundice—Captopril—systemic scleroderma	0.00444	0.00444	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.00439	0.00439	CcSEcCtD
Cefoxitin—Anaemia—Pentoxifylline—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Cefoxitin—Angioedema—Pentoxifylline—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Cefoxitin—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.00426	0.00426	CcSEcCtD
Cefoxitin—Agranulocytosis—Captopril—systemic scleroderma	0.00426	0.00426	CcSEcCtD
Cefoxitin—Bone marrow depression—Methotrexate—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Cefoxitin—Thrombophlebitis—Mycophenolate mofetil—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Cefoxitin—Pancytopenia—Azathioprine—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Cefoxitin—Leukopenia—Pentoxifylline—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Cefoxitin—Eosinophilia—Leflunomide—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Cefoxitin—Convulsion—Pentoxifylline—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Cefoxitin—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Cefoxitin—Pancytopenia—Leflunomide—systemic scleroderma	0.004	0.004	CcSEcCtD
Cefoxitin—Renal failure acute—Mycophenolate mofetil—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Cefoxitin—Neutropenia—Leflunomide—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Cefoxitin—Erythema multiforme—Captopril—systemic scleroderma	0.00387	0.00387	CcSEcCtD
Cefoxitin—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Cefoxitin—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Cefoxitin—Flushing—Captopril—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Cefoxitin—Neutropenia—Mycophenolic acid—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Cefoxitin—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Cefoxitin—Agranulocytosis—Azathioprine—systemic scleroderma	0.00371	0.00371	CcSEcCtD
Cefoxitin—Angioedema—Mometasone—systemic scleroderma	0.00371	0.00371	CcSEcCtD
Cefoxitin—Jaundice—Leflunomide—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Cefoxitin—Haemoglobin—Azathioprine—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Cefoxitin—Eosinophilia—Lisinopril—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Cefoxitin—Hypotension—Pentoxifylline—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Cefoxitin—Haemorrhage—Azathioprine—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Cefoxitin—Agranulocytosis—Leflunomide—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Cefoxitin—Jaundice—Mycophenolic acid—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Cefoxitin—Pancytopenia—Lisinopril—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Cefoxitin—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Cefoxitin—Haemoglobin—Leflunomide—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Cefoxitin—Neutropenia—Lisinopril—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Cefoxitin—Erythema multiforme—Azathioprine—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Cefoxitin—Haemorrhage—Leflunomide—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Cefoxitin—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Cefoxitin—Urinary tract disorder—Leflunomide—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Cefoxitin—Anaphylactic shock—Mometasone—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Cefoxitin—Urethral disorder—Leflunomide—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Cefoxitin—Anaemia—Captopril—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Cefoxitin—Angioedema—Captopril—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Cefoxitin—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Cefoxitin—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Cefoxitin—Erythema multiforme—Leflunomide—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Cefoxitin—Urinary tract disorder—Mycophenolic acid—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Cefoxitin—Urethral disorder—Mycophenolic acid—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Cefoxitin—Jaundice—Lisinopril—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Cefoxitin—Urticaria—Pentoxifylline—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Cefoxitin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Cefoxitin—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Cefoxitin—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Cefoxitin—Agranulocytosis—Lisinopril—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Cefoxitin—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Cefoxitin—Dyspnoea—Mometasone—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Cefoxitin—Anaphylactic shock—Captopril—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Cefoxitin—Thrombophlebitis—Prednisone—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Cefoxitin—Anaemia—Azathioprine—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Cefoxitin—Vaginal inflammation—Methotrexate—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Cefoxitin—Urinary tract disorder—Lisinopril—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Cefoxitin—Thrombocytopenia—Captopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Cefoxitin—Urethral disorder—Lisinopril—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Cefoxitin—Pain—Mometasone—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Cefoxitin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Cefoxitin—Leukopenia—Azathioprine—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Cefoxitin—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Cefoxitin—Erythema multiforme—Lisinopril—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Cefoxitin—Hypotension—Captopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Cefoxitin—Pruritus—Pentoxifylline—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Cefoxitin—Anaemia—Leflunomide—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Cefoxitin—Vaginal infection—Methotrexate—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Cefoxitin—Flushing—Lisinopril—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Cefoxitin—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Cefoxitin—Angioedema—Leflunomide—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Cefoxitin—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Cefoxitin—Leukopenia—Leflunomide—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Cefoxitin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Cefoxitin—Body temperature increased—Mometasone—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Cefoxitin—Abdominal pain—Mometasone—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Cefoxitin—Dyspnoea—Captopril—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Cefoxitin—Anaemia—Mycophenolic acid—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Cefoxitin—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Cefoxitin—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Cefoxitin—Erythema—Lisinopril—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Cefoxitin—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Cefoxitin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Cefoxitin—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Cefoxitin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Cefoxitin—Vomiting—Pentoxifylline—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Cefoxitin—Convulsion—Mycophenolic acid—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Cefoxitin—Rash—Pentoxifylline—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Cefoxitin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Cefoxitin—Thrombophlebitis—Methotrexate—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Cefoxitin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Captopril—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Cefoxitin—Hypotension—Azathioprine—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Cefoxitin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Cefoxitin—Pruritus—Mometasone—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Cefoxitin—Anaemia—Lisinopril—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Cefoxitin—Angioedema—Lisinopril—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Cefoxitin—Abdominal pain—Captopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Cefoxitin—Body temperature increased—Captopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Cefoxitin—Nausea—Pentoxifylline—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Cefoxitin—Diarrhoea—Mometasone—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Cefoxitin—Leukopenia—Lisinopril—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Cefoxitin—Renal failure acute—Methotrexate—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Cefoxitin—Hypotension—Leflunomide—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Cefoxitin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Cefoxitin—Dyspnoea—Leflunomide—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Cefoxitin—Hypotension—Mycophenolic acid—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Cefoxitin—Vomiting—Mometasone—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Cefoxitin—Rash—Mometasone—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Cefoxitin—Dermatitis—Mometasone—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Cefoxitin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Cefoxitin—Pruritus—Captopril—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Cefoxitin—Pain—Leflunomide—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Cefoxitin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Cefoxitin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Cefoxitin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Cefoxitin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Cefoxitin—Neutropenia—Prednisone—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Cefoxitin—Abdominal pain—Azathioprine—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Cefoxitin—Body temperature increased—Azathioprine—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Cefoxitin—Diarrhoea—Captopril—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Cefoxitin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Cefoxitin—Nausea—Mometasone—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Cefoxitin—Pain—Mycophenolic acid—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Cefoxitin—Hypotension—Lisinopril—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Cefoxitin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Cefoxitin—Urticaria—Leflunomide—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Cefoxitin—Abdominal pain—Leflunomide—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Cefoxitin—Body temperature increased—Leflunomide—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Cefoxitin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Cefoxitin—Vomiting—Captopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Cefoxitin—Dyspnoea—Lisinopril—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Cefoxitin—Rash—Captopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Cefoxitin—Dermatitis—Captopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Cefoxitin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Cefoxitin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Cefoxitin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Cefoxitin—Eosinophilia—Methotrexate—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Cefoxitin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Cefoxitin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Cefoxitin—Pain—Lisinopril—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Cefoxitin—Diarrhoea—Azathioprine—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Cefoxitin—Haemoglobin—Prednisone—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Cefoxitin—Nausea—Captopril—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Cefoxitin—Haemorrhage—Prednisone—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Cefoxitin—Pancytopenia—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Cefoxitin—Pruritus—Leflunomide—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Cefoxitin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Cefoxitin—Neutropenia—Methotrexate—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Cefoxitin—Diarrhoea—Leflunomide—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Cefoxitin—Urticaria—Lisinopril—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Cefoxitin—Abdominal pain—Lisinopril—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Cefoxitin—Body temperature increased—Lisinopril—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Cefoxitin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Cefoxitin—Vomiting—Azathioprine—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Cefoxitin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Cefoxitin—Rash—Azathioprine—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Cefoxitin—Dermatitis—Azathioprine—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Cefoxitin—Flushing—Prednisone—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Cefoxitin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Cefoxitin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Cefoxitin—Vomiting—Leflunomide—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Cefoxitin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Cefoxitin—Rash—Leflunomide—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Cefoxitin—Dermatitis—Leflunomide—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Cefoxitin—Nausea—Azathioprine—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Cefoxitin—Erythema—Prednisone—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Cefoxitin—Agranulocytosis—Methotrexate—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Cefoxitin—Pruritus—Lisinopril—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Cefoxitin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Cefoxitin—Haemoglobin—Methotrexate—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Cefoxitin—Rash—Mycophenolic acid—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Cefoxitin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Cefoxitin—Haemorrhage—Methotrexate—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Cefoxitin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Cefoxitin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Cefoxitin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Cefoxitin—Nausea—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Cefoxitin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Cefoxitin—Urethral disorder—Methotrexate—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Cefoxitin—Diarrhoea—Lisinopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Cefoxitin—Anaemia—Prednisone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Cefoxitin—Angioedema—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Cefoxitin—Erythema multiforme—Methotrexate—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Cefoxitin—Nausea—Mycophenolic acid—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Cefoxitin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Cefoxitin—Vomiting—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Cefoxitin—Rash—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Cefoxitin—Convulsion—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Cefoxitin—Dermatitis—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Cefoxitin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Cefoxitin—Erythema—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Cefoxitin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Cefoxitin—Nausea—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Cefoxitin—Anaphylactic shock—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Cefoxitin—Anaemia—Methotrexate—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Cefoxitin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Cefoxitin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Cefoxitin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Cefoxitin—Leukopenia—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Cefoxitin—Convulsion—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Cefoxitin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Cefoxitin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Cefoxitin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.001	0.001	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.001	0.001	CcSEcCtD
Cefoxitin—Urticaria—Prednisone—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Cefoxitin—Abdominal pain—Prednisone—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Cefoxitin—Body temperature increased—Prednisone—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Cefoxitin—Hypotension—Methotrexate—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Cefoxitin—Dyspnoea—Methotrexate—systemic scleroderma	0.000911	0.000911	CcSEcCtD
Cefoxitin—Hypersensitivity—Prednisone—systemic scleroderma	0.000901	0.000901	CcSEcCtD
Cefoxitin—Pain—Methotrexate—systemic scleroderma	0.000874	0.000874	CcSEcCtD
Cefoxitin—Pruritus—Prednisone—systemic scleroderma	0.000865	0.000865	CcSEcCtD
Cefoxitin—Diarrhoea—Prednisone—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Cefoxitin—Urticaria—Methotrexate—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Cefoxitin—Abdominal pain—Methotrexate—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Cefoxitin—Body temperature increased—Methotrexate—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Cefoxitin—Vomiting—Prednisone—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Cefoxitin—Rash—Prednisone—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Cefoxitin—Dermatitis—Prednisone—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Cefoxitin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000753	0.000753	CcSEcCtD
Cefoxitin—Nausea—Prednisone—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Cefoxitin—Pruritus—Methotrexate—systemic scleroderma	0.000723	0.000723	CcSEcCtD
Cefoxitin—Diarrhoea—Methotrexate—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Cefoxitin—Vomiting—Methotrexate—systemic scleroderma	0.00065	0.00065	CcSEcCtD
Cefoxitin—Rash—Methotrexate—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Cefoxitin—Dermatitis—Methotrexate—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Cefoxitin—Nausea—Methotrexate—systemic scleroderma	0.000607	0.000607	CcSEcCtD
